Amalgam Rx is a leading digital platform for SaaS-enabled solutions that bridge the gap between healthcare providers and life sciences companies. With a team boasting over 15 years of experience, they have developed groundbreaking patient support programs and SaMD Digital Therapeutics that revolutionize care delivery. Amalgam's mission is to empower patients and providers to make informed healthcare decisions.

They create and distribute regulated digital products including digital medicine, patient identification, clinical decision support, and clinical trial recruiting. Their modular platform is seamlessly integrated into the EHR workflow, enabling rapid scale across health systems globally. Their algorithms and applications currently support nearly 10 million patients across 4 continents, assisting providers in making over 50 million decisions.

With an exceptional blend of art, science, and technology, Amalgam Rx is at the forefront of the digital health industry. Their esteemed executive team and board of directors, led by CEO Ryan Sysko, have played pivotal roles in transforming care delivery. With a strong focus on innovation and relentless dedication, Amalgam Rx is reshaping the future of healthcare